feed,title,long_url,short_url
BioRxiv,Glyco-engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues,https://biorxiv.org/cgi/content/short/2022.12.22.521646v1?rss=1,https://da.gd/dDO1FA
